AbbVie, Inc. (ABBV)
264.49
-0.47
(-0.18%)
USD |
NYSE |
Aug 24, 16:00
264.58
+0.09
(+0.03%)
After-Hours: 20:00
AbbVie Net Income (Quarterly) : 3.604B for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.604B |
| March 31, 2026 | 687.00M |
| December 31, 2025 | 1.805B |
| September 30, 2025 | 178.00M |
| June 30, 2025 | 931.00M |
| March 31, 2025 | 1.279B |
| December 31, 2024 | -33.00M |
| September 30, 2024 | 1.554B |
| June 30, 2024 | 1.363B |
| March 31, 2024 | 1.362B |
| December 31, 2023 | 813.00M |
| September 30, 2023 | 1.77B |
| June 30, 2023 | 2.016B |
| March 31, 2023 | 230.00M |
| December 31, 2022 | 2.472B |
| September 30, 2022 | 3.934B |
| June 30, 2022 | 917.00M |
| March 31, 2022 | 4.471B |
| December 31, 2021 | 4.024B |
| September 30, 2021 | 3.159B |
| June 30, 2021 | 752.00M |
| March 31, 2021 | 3.531B |
| December 31, 2020 | 22.00M |
| September 30, 2020 | 2.296B |
| June 30, 2020 | -757.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.996B |
| December 31, 2019 | 2.788B |
| September 30, 2019 | 1.874B |
| June 30, 2019 | 733.00M |
| March 31, 2019 | 2.444B |
| December 31, 2018 | -1.822B |
| September 30, 2018 | 2.735B |
| June 30, 2018 | 1.973B |
| March 31, 2018 | 2.771B |
| December 31, 2017 | 52.00M |
| September 30, 2017 | 1.623B |
| June 30, 2017 | 1.906B |
| March 31, 2017 | 1.702B |
| December 31, 2016 | 1.384B |
| September 30, 2016 | 1.59B |
| June 30, 2016 | 1.602B |
| March 31, 2016 | 1.347B |
| December 31, 2015 | 1.509B |
| September 30, 2015 | 1.232B |
| June 30, 2015 | 1.359B |
| March 31, 2015 | 1.017B |
| December 31, 2014 | -805.00M |
| September 30, 2014 | 503.00M |
| June 30, 2014 | 1.091B |
| March 31, 2014 | 976.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Biogen, Inc. | 97.50M |
| Gilead Sciences, Inc. | -10.50B |
| Regeneron Pharmaceuticals, Inc. | 1.297B |
| Amgen, Inc. | 2.375B |
| REGENXBIO, Inc. | 22.71M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.99B |
| Total Expenses (Quarterly) | 13.39B |
| EPS Diluted (Quarterly) | 2.033 |
| Enterprise Value | 532.50B |
| Gross Profit Margin (Quarterly) | 74.71% |
| Profit Margin (Quarterly) | 21.21% |
| Earnings Yield | 1.34% |
| Operating Earnings Yield | 4.69% |
| Normalized Earnings Yield | 3.044 |